More...Snapshot
Deferiprone is an orally bioavailable bidentate ligand with iron chelating activity.1 It binds to iron in a 3:1 (ligand:iron) molar ratio and, thereby, is able to remove excess iron from the body. Deferiprone has been investigated for clinical use in diseases of systemic iron overload
The global Deferiprone market will reach xxx Million USD in 2017 and CAGR xx% 2011-2017. The report begin
Table of Content
1 Industry Overview
1.1 Deferiprone Industry
1.1.1 Overview
1.1.2 Development of Deferiprone
1.2 Market Segment
1.2.1 Upstream
1.2.2 Downstream
1.3 Cost Analysis
2 Industry Environment
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Deferiprone Market by Type
3.1 Segment Overview
3.1.1 Tablet
3.1